Simplex Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,279
Closed -$17.7K 11169
2022
Q3
$10K Buy
+1,279
New +$9.82K ﹤0.01% 8289
2022
Q2
Sell
-70,693
Closed -$342K 11757
2022
Q1
$395K Buy
70,693
+61,640
+681% +$254K ﹤0.01% 4163
2021
Q4
$42K Sell
9,053
-17,663
-66% -$110K ﹤0.01% 7486
2021
Q3
$168K Buy
26,716
+27
+0.1% +$161 ﹤0.01% 5880
2021
Q2
$175K Buy
26,689
+11,035
+70% +$76.1K ﹤0.01% 5900
2021
Q1
$114K Buy
+15,654
New +$135K ﹤0.01% 5575
2019
Q4
Sell
-5,203
Closed -$38.3K 8360
2019
Q3
$43K Buy
5,203
+465
+10% +$3.46K ﹤0.01% 5169
2019
Q2
$31K Buy
4,738
+4,728
+47,280% +$40.5K ﹤0.01% 5257
2019
Q1
$0 Sell
10
-11,919
-100% -$123K ﹤0.01% 8255
2018
Q4
$190K Buy
+11,929
New +$262K ﹤0.01% 3212
2018
Q2
Sell
-5,237
Closed -$124K 8171
2018
Q1
$151K Buy
5,237
+5,171
+7,835% +$151K 0.01% 1462
2017
Q4
$1K Buy
+66
New +$2.05K ﹤0.01% 5791
2017
Q2
Sell
-76
Closed -$598 7173
2017
Q1
$0 Buy
+76
New +$549 ﹤0.01% 7116
2016
Q2
Sell
-690
Closed -$6K 6757
2016
Q1
$6K Buy
690
+320
+86% +$3.17K ﹤0.01% 3996
2015
Q4
$4K Buy
+370
New +$4.4K ﹤0.01% 4110
2015
Q3
Sell
-343
Closed -$4.96K 6522
2015
Q2
$5K Buy
+343
New +$6.17K ﹤0.01% 3722

Simplex Trading's AVEO Position: Q4 2022 in Review

Simplex Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 1,279 shares — an estimated $17.7K sold.

Simplex Trading first reported a position in AVEO in Q2 2015 and held it in 16 quarters. The position peaked at $395K in Q1 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Simplex Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 1,279 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $17.7K.
  • Simplex Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
  • Simplex Trading's AVEO Pharmaceuticals, Inc. position peaked at $395K in Q1 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.